Current issue Volume 6(3); July 2024
-
Re-evaluating the PCSK9 guidelines for low-density lipoprotein cholesterol targets: weighing the benefits against the risks
Terry Gbaa, John Bolodeoku
Cardiovasc Prev Pharmacother. 2024;6(3):85-91.
Review ArticleJuly 30, 2024
-
Health behaviors, knowledge, and attitudes toward cardiovascular disease risk factors in young Iraqi adults: a sample from Erbil, Iraq
Halmat Ahmed Sulaiman, Isil Isik Andsoy
Cardiovasc Prev Pharmacother. 2024;6(3):92-101.
Original ArticleJuly 30, 2024
-
Review ArticleJul 30, 2024
Re-evaluating the PCSK9 guidelines for low-density lipoprotein cholesterol targets: weighing the benefits against the risks
Terry Gbaa, John Bolodeoku
Cardiovasc Prev Pharmacother. 2024;6(3):85-91.
-
Original ArticleJul 30, 2024
Health behaviors, knowledge, and attitudes toward cardiovascular disease risk factors in young Iraqi adults: a sample from Erbil, Iraq
Halmat Ahmed Sulaiman, Isil Isik Andsoy
Cardiovasc Prev Pharmacother. 2024;6(3):92-101.
- MOST CITED
-
- Calcium channel blockers for hypertension: old, but still useful3
- Changes in cardiovascular-related health behaviors during the COVID-19 pandemic2
- Variation in blood viscosity based on the potential cause of stroke of undetermined etiology2
- Decision-making for recurrent atrial fibrillation after catheter ablation2
- Cardiovascular Prevention and Pharmacotherapy
- ENDNOTE STYLE FILE METRICS
v.6(2) 4 2024
v.6(1) 1 2024
v.5(4) 10 2023
v.5(3) 7 2023
v.5(2) 4 2023
v.5(1) 1 2023
v.4(4) 10 2022
v.4(3) 7 2022
v.4(2) 4 2022
v.4(1) 1 2022
